These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11890873)

  • 1. Methotrexate shows marginal clinical efficiency in early scleroderma.
    Varga J
    Curr Rheumatol Rep; 2002 Apr; 4(2):97-8. PubMed ID: 11890873
    [No Abstract]   [Full Text] [Related]  

  • 2. Indirect evidence for the efficacy of methotrexate in diffuse systemic sclerosis.
    Low AH; Lee P
    J Rheumatol; 2008 Nov; 35(11):2286. PubMed ID: 19004063
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of methotrexate in patients with scleroderma and mixed connective tissue disease.
    Kowal-Bielecka O; Distler O
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S160-3. PubMed ID: 21044452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma.
    Pope JE; Bellamy N; Seibold JR; Baron M; Ellman M; Carette S; Smith CD; Chalmers IM; Hong P; O'Hanlon D; Kaminska E; Markland J; Sibley J; Catoggio L; Furst DE
    Arthritis Rheum; 2001 Jun; 44(6):1351-8. PubMed ID: 11407694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disappearance of circulating autoantibodies to RNA polymerase III in a patient with systemic sclerosis successfully treated with corticosteroid and methotrexate.
    Tanahashi K; Sugiura K; Muro Y; Akiyama M
    J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1453-4. PubMed ID: 24916000
    [No Abstract]   [Full Text] [Related]  

  • 6. Mucosa-associated lymphoid tissue lymphoma (MALT) of salivary glands and scleroderma: a case report.
    Prochorec-Sobieszek M; Mielnik P; Wagner T; Chwalińska-Sadowska H
    Clin Rheumatol; 2004 Aug; 23(4):348-50. PubMed ID: 15293098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive sclerodermatous skin changes in a child with phenylketonuria.
    Al-Mayouf SM; Al-Owain MA
    Pediatr Dermatol; 2006; 23(2):136-8. PubMed ID: 16650221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of dermatologic lesions using immunosuppressive agents and cytostatics].
    Schuppli R
    Munch Med Wochenschr; 1970 Mar; 112(12):526-30. PubMed ID: 5467837
    [No Abstract]   [Full Text] [Related]  

  • 9. Widespread soft tissue calcification in systemic sclerosis, polymyositis, and polyarthritis.
    Hudowenz O; Klemm P; Lange U; Mueller-Ladner U
    Lancet; 2021 Jan; 397(10272):409. PubMed ID: 33516339
    [No Abstract]   [Full Text] [Related]  

  • 10. Scleroderma in children: an update.
    Zulian F; Cuffaro G; Sperotto F
    Curr Opin Rheumatol; 2013 Sep; 25(5):643-50. PubMed ID: 23912318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stabilization of Microcirculation in Patients with Early Systemic Sclerosis with Diffuse Skin Involvement following Rituximab Treatment: An Open-label Study.
    Smith V; Pizzorni C; Riccieri V; Decuman S; Brusselle G; DE Pauw M; Deschepper E; Piette Y; Ruaro B; Sulli A; Vandecasteele E; Melsens K; DE Keyser F; Cutolo M
    J Rheumatol; 2016 May; 43(5):995-6. PubMed ID: 27134280
    [No Abstract]   [Full Text] [Related]  

  • 12. [Current treatment of systemic sclerosis. Part I. Immunosuppressive treatment].
    Sicińska J; Rudnicka L
    Pol Merkur Lekarski; 2008 Aug; 25(146):192-5. PubMed ID: 18942346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scleroderma in children.
    Zulian F
    Best Pract Res Clin Rheumatol; 2017 Aug; 31(4):576-595. PubMed ID: 29773274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunosuppressive agents for therapy of autoimmune diseases of the skin and of psoriasis].
    Ruszczak Z
    Hautarzt; 1977 Mar; 28(3):125-31. PubMed ID: 15957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppression with chlorambucil, versus placebo, for scleroderma. Results of a three-year, parallel, randomized, double-blind study.
    Furst DE; Clements PJ; Hillis S; Lachenbruch PA; Miller BL; Sterz MG; Paulus HE
    Arthritis Rheum; 1989 May; 32(5):584-93. PubMed ID: 2655606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chorioretinitis in a 7-year-old African girl, probably related to JSSc resolving to methotrexate therapy.
    Hedrich CM; Leszczynska A; Hammermann J; Bau V; Gahr M
    Klin Padiatr; 2011 Mar; 223(2):92-4. PubMed ID: 21294066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Practical use of immunosuppressive and cytostatic drugs in dermatological diseases].
    Schuppli R
    Minerva Med; 1970 Jul; 61(55):3070-3. PubMed ID: 5427679
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunosuppressive therapy. 1.
    Skinner MD; Schwartz RS
    N Engl J Med; 1972 Aug; 287(5):221-7. PubMed ID: 4556641
    [No Abstract]   [Full Text] [Related]  

  • 19. Methotrexate for the treatment of early diffuse scleroderma: comment on the article by Pope et al.
    Lehman TJ
    Arthritis Rheum; 2002 Mar; 46(3):845. PubMed ID: 11920427
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of oral methotrexate in the treatment of systemic sclerosis.
    Krishna Sumanth M; Sharma VK; Khaitan BK; Kapoor A; Tejasvi T
    Int J Dermatol; 2007 Feb; 46(2):218-23. PubMed ID: 17269983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.